-transparent.png){kind=logo}
1 Fourteen maturity onset diabetics showed improvement of glucose tolerance while on treatment with clofibrate. Fasting blood glucose levels were reduced by 20% after treatment for 14 and 28 days. 2 The effect was found to be independent of concurrent treatment with oral hypoglycaemic drugs. 3 Plasma insulin levels were also lower during clofibrate treatment. 4 Clofibrate may prove to be a useful adjunct to the treatment of maturity onset diabetes.
Related Publications
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
July 1978,
Metabolism: clinical and experimental,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
September 1986,
Journal of ethnopharmacology,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
January 1979,
Diabetes,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
March 1967,
Lancet (London, England),
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
June 1978,
Biomedicine / [publiee pour l'A.A.I.C.I.G.],
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
January 1984,
Duodecim; laaketieteellinen aikakauskirja,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
January 1977,
The Journal of the Egyptian Public Health Association,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
January 1977,
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
March 1972,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D Barnett, and
J G Craig, and
D S Robinson, and
M P Rogers
November 1980,
British medical journal,
